Eballena, Zaye Seff .
HRN: 23-47-03 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/11/2023
09/17/2023
IV
180mg
Q6
PCAP D
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes